Judy R. Joice
Net Worth
Last updated:
What is Judy R. Joice net worth?
The estimated net worth of Ms. Judy R. Joice is at least $2,228,904 as of 14 May 2021. She owns shares worth $65,484 as insider, has earned $130,870 from insider trading and has received compensation worth at least $2,032,550 in DURECT Corporation.
What is the salary of Judy R. Joice?
Ms. Judy R. Joice salary is $406,510 per year as Senior Vice President of Operations & Corporation Quality Assurance in DURECT Corporation.
How old is Judy R. Joice?
Ms. Judy R. Joice is 68 years old, born in 1957.
What stocks does Judy R. Joice currently own?
As insider, Ms. Judy R. Joice owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| DURECT Corporation (DRRX) | Senior Vice President of Operations & Corporation Quality Assurance | 34,832 | $1.88 | $65,484 |
What does DURECT Corporation do?
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogenous, orally bioavailable small molecule that is in Phase IIb clinical trial to play a regulatory role in lipid metabolism, stress and inflammatory responses, and cell death and survival to treat alcohol-associated hepatitis, as well as completed Phase Ib clinical trial to treat patients with nonalcoholic steatohepatitis. In addition, the company offers POSIMIR, a post-surgical pain product to deliver bupivacaine up to days of in adults; and Methydur to treat attention deficit hyperactivity disorder. It markets and sells its ALZET lines through direct sales force in the United States, as well as through a network of distributors in Japan, Europe, and internationally. The company has strategic collaboration and other agreements with Virginia Commonwealth University Intellectual Property Foundation; Indivior UK Ltd.; and Santen Pharmaceutical Co., Ltd. DURECT Corporation was incorporated in 1998 and is headquartered in Cupertino, California.
Judy R. Joice insider trading
DURECT Corporation
Ms. Judy R. Joice has made 2 insider trades between 2020-2021, according to the Form 4 filled with the SEC.
The largest trade she's ever made was exercising 60,137 units of DRRX stock on 14 May 2021. As of 14 May 2021 she still owns at least 34,832 units of DRRX stock.
DURECT key executives
DURECT Corporation executives and other stock owners filed with the SEC:
- Dr. James E. Brown D.V.M. (68) Co-Founder, Chief Executive Officer, Pres & Director
- Dr. Norman L. Sussman (72) Chief Medical Officer
- Mr. Michael H. Arenberg (55) Chief Financial Officer & Sec.
- Ms. Judy R. Joice (68) Senior Vice President of Operations & Corporation Quality Assurance